Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

Detalles Bibliográficos
Autores principales: Lum, Lawrence G, Choi, Minsig, Thakur, Archana, Deol, Abhinav, Fields, Kristie, Tomaszewski, Elyse, Schalk, Dana, Kondadasule, Vidya, Dyson, Greg, Mahaseth, Hemchandra, Philip, Philip, Shields, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645487/
http://dx.doi.org/10.1186/2051-1426-3-S2-P55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645487/
http://dx.doi.org/10.1186/2051-1426-3-S2-P55

Ejemplares similares